3rd Party Medical Device Industry News

MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism

Following End-of-Phase 2 meeting, MBX remains on track to initiate [...]

By |2026-03-09T16:09:30+00:00March 9, 2026|3rd Party Medical Device Industry News|Comments Off on MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism

Philips unveils Rembra CT at ECR 2026, setting a new benchmark for speed and patient access designed to support diagnostic confidence for acute and high-demand imaging environments

CE Marked and 510(k) pending, Rembra’s advanced image reconstruction technology [...]

By |2026-03-05T14:25:51+00:00March 5, 2026|3rd Party Medical Device Industry News|Comments Off on Philips unveils Rembra CT at ECR 2026, setting a new benchmark for speed and patient access designed to support diagnostic confidence for acute and high-demand imaging environments
Go to Top